Inex Plans Complete Spin-Out Into Tekmira In September
This article was originally published in The Pink Sheet Daily
Executive Summary
Previous spin-out Protiva has filed suit to stop the firm from moving almost all of its assets into a new company.
You may also be interested in...
Alnylam Seeks To Advance RNAi Further With Inex Delivery Technology
There is an "open invitation" to companies and academia to partner with Inex on RNAi therapies, Inex CEO tells "The Pink Sheet" DAILY.
Alnylam Seeks To Advance RNAi Further With Inex Delivery Technology
There is an "open invitation" to companies and academia to partner with Inex on RNAi therapies, Inex CEO tells "The Pink Sheet" DAILY.
Inex Restructures: COO Is Timothy Ruane, Senior Execs Depart
Inex is shedding 60% of its workforce in a cost-cutting move aimed at reducing cash burn to under $1 mil. a month. CEO David Main and senior execs depart under reorganization, the second since an advisory committee’s unfavorable recommendation for Inex’ oncologic Marqibo.